Streetbeat News

Price Targets

PTLO

Morgan Stanley analyst Brian Harbour has maintained an Overweight rating on Portillos (NASDAQ:PTLO) but lowered the price target from $28 to $26.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:45 pm

PLNT

Morgan Stanley analyst Kristine Liwag maintains an Overweight rating on Planet Fitness (NYSE:PLNT) but lowers the price target from $88 to $84.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:44 pm

RL

Telsey Advisory Group analyst Dana Telsey has reiterated an Outperform rating on Ralph Lauren Corporation (NYSE:RL), raising the price target to $155 from $140. The analyst expects Q1 EPS of $2.09, net revenue to be down 0.5% Y/Y to $1.48 billion, and a flat operating margin of 12.7%. Telsey applauds RL's recent developments, including expansion in underpenetrated categories, and expects these to deliver accelerated topline growth.

Portfolio Pulse from Nabaparna Bhattacharya

August 04, 2023 | 6:37 pm

PACB

Morgan Stanley analyst Tejas Savant has reiterated an Equal-Weight rating on Pacific Biosciences (NASDAQ:PACB) and maintained a $13 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:31 pm

NUVA

Morgan Stanley analyst Jonathan Demchick has maintained an Equal-Weight rating on NuVasive (NASDAQ:NUVA) and raised the price target from $40 to $45.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:27 pm

NCLH

Morgan Stanley analyst Stephen Grambling has reiterated an Underweight rating on Norwegian Cruise Line (NYSE:NCLH) and maintained a $14.5 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:25 pm

NRDS

Morgan Stanley analyst James Faucette has maintained an Equal-Weight rating on Nerdwallet (NASDAQ:NRDS) and lowered the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:24 pm

MSI

Morgan Stanley analyst Erik Lapinski has maintained an Equal-Weight rating on Motorola Solutions (NYSE:MSI) and raised the price target from $290 to $300.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:23 pm

MNST

Morgan Stanley analyst Dara Mohsenian has reiterated an Overweight rating on Monster Beverage (NASDAQ:MNST) and maintained a $63 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:20 pm

MRNA

Morgan Stanley analyst Matthew Harrison has maintained an Equal-Weight rating on Moderna (NASDAQ:MRNA) and lowered the price target from $128 to $123.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 6:19 pm